Trypanosoma cruzi Mitochondrial Peroxiredoxin Promotes Infectivity in Macrophages and Attenuates Nifurtimox Toxicity

Trypanosoma cruzi is the causative agent of Chagas disease which is currently treated by nifurtimox (NFX) and benznidazole (BZ). Nevertheless, the mechanism of action of NFX is not completely established. Herein, we show the protective effects of T. cruzi mitochondrial peroxiredoxin (MPX) in macroph...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Gabriela Specker, Damián Estrada, Rafael Radi, Lucía Piacenza
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2022-02-01
Saila:	Frontiers in Cellular and Infection Microbiology
Gaiak:	T. cruzi nifurtimox mitochondrial peroxiredoxin macrophage infection holdase and peroxidase activities
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.749476/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!